Clinical trials
Phase 2 Inflammation trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 2 |
| Unknown status | 2 |
| Completed | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Abcentra | 1 |
| Claes-Göran Östenson | 1 |
| Hans Törnblom | 1 |
| Mogens Bove | 1 |
| Uppsala University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammation | 7 |
| Crohn Disease | 2 |
| Diabetes Mellitus | 2 |
| Acute Coronary Syndrome | 1 |
| Diabetes Mellitus, Type 1 | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Endocrine System Diseases | 1 |
| Eosinophilic Esophagitis | 1 |
| Esophagitis | 1 |
| Glucose Intolerance | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.